Arecor Therapeutics plc (AREC.L)
GBp 38.0
(0.0%)
GBp 38.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 4.57 Million GBP | 90.3% |
| 2022 | 2.4 Million GBP | 107.51% |
| 2021 | 1.15 Million GBP | -31.79% |
| 2020 | 1.69 Million GBP | -10.23% |
| 2019 | 1.89 Million GBP | 152.92% |
| 2018 | 747.67 Thousand GBP | -44.62% |
| 2017 | 1.35 Million GBP | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 997.5 Thousand GBP | 100.0% |
| 2024 Q1 | 997.5 Thousand GBP | -31.3% |
| 2023 Q4 | 1.45 Million GBP | 0.0% |
| 2023 FY | 4.57 Million GBP | 90.3% |
| 2023 Q2 | 1.66 Million GBP | 100.0% |
| 2023 Q3 | 1.45 Million GBP | -13.0% |
| 2023 Q1 | 834.5 Thousand GBP | -51.2% |
| 2022 Q2 | 693 Thousand GBP | 100.0% |
| 2022 Q1 | 346.5 Thousand GBP | -50.36% |
| 2022 Q4 | 1.71 Million GBP | 100.0% |
| 2022 FY | 2.4 Million GBP | 107.51% |
| 2022 Q3 | 855 Thousand GBP | 23.38% |
| 2021 Q3 | 349 Thousand GBP | -24.13% |
| 2021 Q2 | 460.02 Thousand GBP | 100.01% |
| 2021 FY | 1.15 Million GBP | -31.79% |
| 2021 Q1 | 230 Thousand GBP | -73.89% |
| 2021 Q4 | 697.97 Thousand GBP | 99.99% |
| 2020 Q3 | 440.47 Thousand GBP | -46.09% |
| 2020 Q2 | 817.04 Thousand GBP | 100.0% |
| 2020 Q1 | 408.52 Thousand GBP | 0.0% |
| 2020 FY | 1.69 Million GBP | -10.23% |
| 2020 Q4 | 880.95 Thousand GBP | 100.0% |
| 2019 FY | 1.89 Million GBP | 152.92% |
| 2018 FY | 747.67 Thousand GBP | -44.62% |
| 2017 FY | 1.35 Million GBP | 0.0% |
| Name | Revenue | Revenue Difference |
|---|